
4D Molecular Therapeutics, Inc. (FDMT)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
10.06 - Open
10.48 - Bid 10.47 x 300
- Ask 10.53 x 200
- Day's Range
10.21 - 10.74 - 52 Week Range
2.96 - 12.34 - Volume
894,935 - Avg. Volume
765,588 - Market Cap (intraday)
535.53M - Beta (5Y Monthly) 2.93
- PE Ratio (TTM)
-- - EPS (TTM)
-2.42 - Earnings Date (est.) May 7, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
28.78
Recent News: FDMT
View MorePerformance Overview: FDMT
Trailing total returns as of 4/17/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: FDMT
View MoreAnalyst Insights: FDMT
View MoreStatistics: FDMT
View MoreValuation Measures
-
Market Cap
514.09M
-
Enterprise Value
132.85M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
6.85
-
Price/Book (mrq)
1.02
-
Enterprise Value/Revenue
1.56
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-164.43%
-
Return on Assets (ttm)
-17.34%
-
Return on Equity (ttm)
-27.57%
-
Revenue (ttm)
85.21M
-
Net Income Avi to Common (ttm)
-140.11M
-
Diluted EPS (ttm)
-2.42
Balance Sheet and Cash Flow
-
Total Cash (mrq)
402.66M
-
Total Debt/Equity (mrq)
4.24%
-
Levered Free Cash Flow (ttm)
-54.15M
Compare To: FDMT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.





